Medication-Related Osteonecrosis of the Jaw
New England Journal of Medicine · 2023
DOI: 10.1056/nejmicm2209172 ↗Kurz gefasst
Fallbericht in der Zeitschrift New England Journal of Medicine, 2023. Verfasst von Yu-Feng Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Diphosphonates, Bisphosphonate-Associated Osteonecrosis of the Jaw. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
A 54-year-old woman with metastatic breast cancer who was receiving denosumab therapy presented with right jaw pain. An area of exposed, necrotic bone was visualized in the right mandible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
- Kaohsiung Medical University, Kaohsiung, Taiwan chang610004@gmail.com.
ORCID-Profile: Yu-Feng Chen
Zitieren
APA
Chen, Y. F., & Chang, H. P. (2023). Medication-Related Osteonecrosis of the Jaw. New England Journal of Medicine. https://doi.org/10.1056/nejmicm2209172
Vancouver
Chen YF, Chang HP. Medication-Related Osteonecrosis of the Jaw. New England Journal of Medicine. 2023. doi:10.1056/nejmicm2209172
BibTeX
@article{Chen2023,
author = {Chen, Yu-Feng and Chang, Hong-Po},
title = {Medication-Related Osteonecrosis of the Jaw},
journal = {New England Journal of Medicine},
year = {2023},
doi = {10.1056/nejmicm2209172}
}
EUVIMED